Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.

Leung W, Reddel HK, Hung T, Weatherall M, Pelzer I, Holliday M, Sullivan T, Harrison T, Pavord ID, Baker MG, Ebmeier S, Papi A, Beasley R, Hancox RJ

Open source

DOI
10.1183/23120541.00949-2025
Published
2026 Jan
Container
ERJ open research
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00949-2025,
  title = {Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.},
  author = {Leung W and Reddel HK and Hung T and Weatherall M and Pelzer I and Holliday M and Sullivan T and Harrison T and Pavord ID and Baker MG and Ebmeier S and Papi A and Beasley R and Hancox RJ},
  year = {2026},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00949-2025},
  url = {https://doi.org/10.1183/23120541.00949-2025}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.
AU  - Leung W
AU  - Reddel HK
AU  - Hung T
AU  - Weatherall M
AU  - Pelzer I
AU  - Holliday M
AU  - Sullivan T
AU  - Harrison T
AU  - Pavord ID
AU  - Baker MG
AU  - Ebmeier S
AU  - Papi A
AU  - Beasley R
AU  - Hancox RJ
PY  - 2026
JO  - ERJ open research
DO  - 10.1183/23120541.00949-2025
UR  - https://doi.org/10.1183/23120541.00949-2025
ER  - 

APA

W, L., HK, R., T, H., M, W., I, P., M, H., T, S., T, H., ID, P., MG, B., S, E., A, P., R, B., & RJ, H. (2026). Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.. ERJ open research. https://doi.org/10.1183/23120541.00949-2025

Source records